Across TCGA pan-cancer cohorts, RNA5SP87 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNA5SP87 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNA5SP87 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP87 expression acts as an unfavorable survival marker.
KIRC and KIRP are the cancer types where RNA5SP87 RNA most reproducibly stratifies survival.